Friend murine erythroleukaemia (F-MEL) cells are a useful model for studying the processes that regulate erythroid differentiation since exposure of these cells to chemical inducers (DMSO or HMBA) results in commitment to terminal cell division and synthesis of haemoglobin. This study examined the relationship between differentiation and apoptosis in DMSO sensitive and resistant F-MEL cells. Clear apoptosis was not observed in DMSO-treated sensitive F-MEL (strain 745A) cells during the induction of differentiation. In contrast, DMSO-induced 745A cells exhibited delayed apoptosis compared to uninduced cells. Since the Bcl-2 family members play a major role in the control of apoptosis and/or differentiation, we determined their expression before and after DMSO or HMBA treatment. Neither untreated nor chemically-induced 745A cells expressed the Bcl-2 protein.
Introduction
Friend murine erythroleukaemia (F-MEL) cells are virustransformed erythroid precursor cells blocked at a relatively early stage in erythroid differentiation. This arrest can be overcome by exposure to DMSO or a variety of other chemical inducers. 1 Friend cell differentiation is a model for studying the mechanism of erythroid maturation since induced F-MEL cells undergo phenotypic changes that resemble the final stages of normal erythropoiesis. Incubation of F-MEL cells with DMSO or HMBA leads to two major programmes which are associated during terminal erythroid differentiation of these cells. One programme is responsible for haemoglobin synthesis and the other for commitment to terminal maturation with a loss of proliferative capacity after four or five cell divisions. 2 ± 5 However, these two programms can operate independently despite their co-ordination during DMSO-induced differentiation. For example, commitment to terminal cell division occurs in the absence of haemoglobin synthesis in DMSO-induced F-MEL cells treated with imidazole 6 or succinylacetone. 7, 8 Associated with terminal myeloid differentiation is acquisition of the ability to undergo apoptosis. However, the survival of mature haematopoietic cells differs between the lineages. For instance, upon reaching terminal granulocytic differentiation HL-60 leukaemic cells undergo apoptosis, whereas their viability is not affected during differentiation along the monocyte/macrophage lineage. 9, 10 The difference in life span between these two lineages might reflect a difference in the expression of survival genes. Among the Bcl-2 family genes which are involved in the regulation of the survival of haematopoietic cells, 11 a major role for the anti-apoptotic protein Bcl-X L in maintaining primitive haematopoietic cells is supported by studies of Cell Death and Differentiation (1999) 6, 166 ± 174
Bcl-X L -deficient mice, which develop massive cell death of haematopoietic progenitor cells. 12 Moreover, recent studies suggest that Bcl-X L may also regulate the life span of mature haematopoietic cells. The expression of Bcl-X L is downregulated during granulocytic differentiation and enhanced during monocytic differentiation in HL-60 cells. 9, 10 Similarly a recent report suggests an important role of Bcl-X L upregulation in the control of erythropoiesis by erythropoietin during the later phases of erythroid differentiation. 13 Erythropoietin (Epo) is required by late-stage erythroid progenitors cells to prevent apoptosis. 14, 15 In contrast to Epo-dependent murine erythroleukaemia cell lines derived from FVA-infected cells, F-MEL continuous cell lines derived from FVP-infected cells do not require Epo for survival and do not differentiate in the presence of Epo. 16 Differentiation is induced instead by chemicals. Little is known about whether viability of F-MEL cells is affected during and/or after the induction of chemically-induced differentiation. The F-MEL cells must possess a mechanism to avoid apoptosis during the process of differentiation, allowing the development of mature cells to perform their regulatory functions. To avoid apoptosis and complete the differentiation process, a cell would require an intrinsic mechanism to escape the death process (an intrinsic survival mechanism). Moreover, whereas the F-MEL cells which have reached terminal maturation are thought to cease to proliferate, it is not clear whether these cells undergo apoptosis. In this study, we have investigated the relationship between differentiation and apoptosis in DMSO sensitive and resistant F-MEL cells. Surprisingly, we find that the DMSO-treated F-MEL cells exhibit delayed apoptosis compared to untreated cells. We also determined the expression of the Bcl-2 family members during F-MEL cell differentiation. DMSO or HMBA treatment of F-MEL cells induced a marked increase in Bcl-X L expression, suggesting a role for this anti-apoptotic protein in erythroid differentiation of F-MEL cells. Moreover, our results show that Bcl-X L induction during this process occurs independently of haemoglobin synthesis.
Results

Delay of apoptosis in DMSO-treated F-MEL 745A cells
We studied the lifespan of the differentiation-sensitive 745A F-MEL cell line by serial cell counts and viability determinations at various times after induction with DMSO treatment ( Figure  1 ). During the first 3 days of culture, there was no evidence of dead cells in untreated and treated cells ( Figure 1A ). After 3 days of undiluted culture, the density of untreated or DMSOtreated cells remained essentially unchanged at a plateau of 2 ± 3610 6 cells/ml ( Figure 1B ). However, viability decreased after day 3 of culture in untreated 745A cells. In contrast, no dead cells were detected in DMSO-treated cells by 4 days ( Figure 1A ). After 5 days of DMSO treatment when about 90% of cells are differentiated (as reflected by benzidine staining), 90% are still viable ( Figure 1A and C) . A clear loss of viability was seen after 6 days of DMSO treatment.
In order to assess the nature of cell death observed in 745A cells, DNA fragmentation was analyzed in these cells. Figure 2A shows that genomic DNA from 745A cells cultured in the absence of DMSO was degraded into oligonucleosomal fragments at 4 days while DNA degradation was not evident before 5 days in DMSO-treated 745A cells. To confirm that the prolonged lifespan of DMSOtreated cells resulted from an inhibition of apoptosis, cells were also examined with acridine orange/ethidium bromide staining ( Figure 2B ). The results indicate that a delay of Increase of Bcl-X L in DMSO-treated F-MEL cells is not correlated with cell density but with G0/G1 arrest Untreated or DMSO-treated 745A cells seeded at low density (10 5 cells/ml) after a short delay grew exponentially for 2 ± 3 days and in absence of being diluted, reached similar high cell densities (42610 6 cells/ml) (see Figure  1B) . However terminal maturation of DMSO-treated F-MEL cells is characterized by a loss of proliferative potential and cessation of DNA synthesis. 3, 5 When 745A cells cultured in suspension were diluted on day 2 and day 4 at 10 5 cells/ ml, they grew logarithmically after each transfer in medium without DMSO but they progressively lost the capacity to grow in culture containing DMSO ( Figure 5A ). These findings are consistent with cell cycle analysis which showed that DMSO caused an accumulation of 745A cells in the G0/G1 phase of the cell cycle ( Figure 5B ). When untreated 745A cells were undiluted and grown to a high density, an increasing proportion of cells was also observed in G0/G1 phase approaching that observed in DMSO-treated cells. However, after one or two dilutions, untreated cultures maintained a consistent cell cycle distribution with 50 ± 55% G0/G1 cells whereas cultures grown in the presence of DMSO accumulated 80 ± 90% G0/G1 cells on day 6. When we examined the expression of Bcl-X L after one or two dilutions, an increase of Bcl-X L was observed after 6 days of DMSO treatment in both cases ( Figure 5C ). These results suggest that the increase of Bcl-X L in DMSO-induced 745A cells is independent of cell density and seems to be correlated with accumulation of cells in G0/G1.
Expression of Bcl-X L in F-MEL cells resistant to haemoglobinization by DMSO
To investigate whether induction of Bcl-X L in DMSOtreated 745A cells was due to erythroid differentiation or to DMSO-treatment, we examined the expression of Bcl-X L protein in a Friend cell line (TFP10) partially resistant to DMSO differentiation. 17 After 5 days of DMSO treatment only 18% of TFP10 cells were benzidinepositive while 90% of 745A cells made haemoglobin ( Table 1 ). The effect of DMSO on commitment to terminal cell division of TFP10 cells was also examined and compared with 745A cells. Figure 6 shows that TFP10 cells progressively lost the capacity to grow in suspension culture containing DMSO. These findings indicate that TFP10 cells, which are resistant to induction of haemoglobin synthesis by DMSO or HMBA, are nevertheless sensitive to inducer-mediated commitment to terminal cell division. Figure 7A shows that DMSO or HMBA induced an increase of Bcl-X L expression in TFP10 cells after 4 days of treatment. Since the level of Bcl-X L expression may be related to the survival of TFP10 cells after DMSO treatment, we also examined the viability of these cells. DMSO treatment of TFP10 cells resulted in a delay of 
Prevention of Bcl-X L induction in DMSO-treated F-MEL cells by dexamethasone but not by imidazole or succinylacetone
To further test whether the increase of Bcl-X L expression after DMSO treatment was associated with the commitment to terminal maturation, we have examined the effect of different inhibitors of Friend erythroid differentiation. Dexamethasone suppresses not only haemoglobin accumulation (Table 1 ) but also inhibition of terminal cell division induced by DMSO.
18 Bcl-X L expression did not increase during treatment with both DMSO and dexamethasone nor during treatment with HMBA and dexamethasone ( Figure 8A ). Treatment of F-MEL cells with imidazole (IM), in the presence of DMSO, dissociates haemoglobin synthesis from commitment to terminal maturation. 6 Similarly, the presence of succinylacetone (SA), a specific inhibitor of haeme biosynthesis, prevents haemoglobinization of F-MEL cells but does not prevent them from losing their proliferative capacity when treated with DMSO. 8 We tested the effects of these two inhibitors on haemoglobin synthesis and on Bcl-X L expression in DMSO-treated 745A cells ( Figure 8B and C). Although both inhibitors blocked haemoglobinization, high levels of Bcl-X L were still present in the 745A cells induced by DMSO and treated by SA or IM.
Discussion
The present results show that induction of differentiation in F-MEL cells by the chemical inducers DMSO or HMBA is associated with increased Bcl-X L expression. The upregulation of Bcl-X L occurs late in this process 4 days after induction when the differentiation-sensitive 745A cells synthesize haemoglobin (80% of benzidine-positive cells). The induction of Bcl-X L is not observed when DMSO-induced erythroid differentiation is prevented by dexamethasone. However, the increase of Bcl-X L is not correlated with the amount of haemoglobin synthesis since the TFP10 cell line induced by DMSO produces similar high levels of Bcl-X L with only 18% of benzidine staining cells. An increase of Bcl-X L was recently reported during the terminal phases of erythroid differentiation using the Friend FVA cell system. 13 Bcl-X L expression in FVAinfected cells parallels the synthesis of haeme and haemoglobin in these cells cultured with Epo. This system is different from the Friend FVP cell system used in our study since FVA cells require Epo for survival, differentiate in the presence of Epo, and the strong upregulation of Bcl-X L is completely dependent on exposure to Epo. 745A and TFP10 cells are Epo-independent and do not differentiate in response to Epo but only in response to chemical inducers. Our results suggest that Bcl-X L accumulation during the late phases of erythroid differentiation is independent of the agents used to induce the process.
Mice deficient in Bcl-X L develop massive cell death of haematopoietic progenitor cells suggesting that the apoptosis inhibitory protein Bcl-X L 19 is involved in maintaining the survival of haematopoietic cells. 12 Recently, it was shown that monocytic differentiation of HL-60 promyelocytic leukaemia cells correlates with the induction of Bcl-X L and enhancement of cell survival. 9 By contrast Bcl-X L is downregulated during differentiation in mature granulocytes with a limited life span. 10 These results suggest a role of Bcl-X L expression in maintaining the survival of differentiated haematopoietic cells. Moreover, Epo upregulates the expression of Bcl-X L in different Epodependent cell lines and this seems to be a major mechanism by which Epo maintains the viability of erythroid progenitor cells. 13, 20 The F-MEL cells used in our study do not require Epo for their survival. Initiation of apoptosis was observed, however, after 4 days of culture in control untreated 745A cells, while a delay of apoptosis occurred in DMSO-treated 745A cells. A similar delay in apoptosis was observed during DMSO treatment in TFP10 cells suggesting that the induction of Bcl-X L by DMSO in F-MEL cells may contribute to the delay of apoptosis. Since these cells do not contain the anti-apoptotic Bcl-2 protein, it is possible that the induction of Bcl-X L is necessary to prolong survival during the late phase of DMSO-induced All data represent the mean of triplicate cultures+standard deviation differentiation, thus allowing the development of the process. However, high levels of Bcl-X L persist even after the onset of apoptosis on day 7, indicating that Bcl-X L is not sufficient to prevent death after differentiation. The respective role of Bcl-2 and Bcl-X L genes in regulating apoptosis of F-MEL cells will be studied in stable transfectants using sense or antisense expression vectors.
It was reported that suppression or delay of apoptosis by Bcl-2 results in haematopoietic cell differentiation when cells have the preprogrammed capacity for differentiation. 21 ± 23 Since the F-MEL cells have a predetermined differentiation programme, 24 the delay of apoptosis induced by DMSO could allow the erythroid differentiation of F-MEL cells. However, the delay of apoptosis is not sufficient to induce complete erythroid differentiation in F-MEL cells, since TFP10 cells treated by DMSO are partially defective in producing haemoglobin. It is also possible that Bcl-X L induction is not correlated with the production of haemoglobin, but rather with the arrest of proliferation induced by DMSO in F-MEL cells during the differentiation process. Consistent with this possibility are our results observed with different inhibitors which dissociate the programme of commitment to terminal cell division from haemoglobin accumulation. 6, 8 The F-MEL cells induced by DMSO to terminal division, but inhibited in haemoglobin synthesis by imidazole or succinylacetone, expressed high levels of Bcl-X L . The latter results suggest that induction of Bcl-X L in Friend erythroid differentiation is not correlated with haemoglobin synthesis. Moreover, the finding that haemoglobinization-resistant TFP10 cells cease to proliferate after DMSO induction, in a similar manner to 745A cells, indicate that induction of Bcl-X L may be related to the programme causing loss of cell division.
Our studies add to the evidence that upregulation of Bcl-X L is associated with the terminal differentiation of normal or leukaemic erythroid cells. 13 However, other studies using human erythroleukaemia K562 or HEL cell lines have shown a down regulation of Bcl-X L associated with activation of apoptosis after induction of erythroid differentiation with hemin, retinoic acid or transforming growth factor-b. 25 Although these results seem contradictory, it is noteworthy that both K562 and HEL cell lines expressed erythroid and megakaryocytic properties and high levels of Bcl-X L before induction. 26 Moreover, differentiation of K562 cells by erythroid inducers is associated with an increase of haemoglobin synthesis but not always with an irreversible cell terminal division. 27 Our studies show that the upregulation of Bcl-X L during DMSO induction of F-MEL cells is not correlated with haemoglobinization but rather with their accumulation in the G0/G1 phase of the cycle. It is possible that Bcl-X L induction in DMSO-treated F-MEL cells facilitates erythroid differentiation not only by delaying apoptosis but also by inducing cell cycle arrest or by inhibiting re-entry of differentiating cells into the cell cycle as recently described for Bcl-2. 28, 29 The possibility that Bcl-X L favours quiescence over the cycling state when cells undergo terminal erythroid differentiation remains to be explored.
In conclusion, our results indicate that chemical induction of erythroid differentiation in F-MEL cells correlates with a delay of apoptosis and a specific induction of the Bcl-X L protein. We also show that Bcl-X L induction does not seem to be associated with the programme of haemoglobin synthesis but correlates with the programme responsible for cessation of cell division. These results open new perspectives concerning the role of Bcl-X L in terminal differentiation.
Materials and Methods
Chemicals and antibodies
DMSO was from BDH and HMBA, dexamethasone, imidazole and succinylacetone were from Sigma. The primary antibodies used in Western were mouse monoclonal anti-Bcl-2 (human) from DAKO; rabbit polyclonal anti-Bcl-X (human) and mouse monoclonal anti-Bad (mouse) from Transduction Laboratories; and rabbit polyclonal antiBax (mouse) from Pharmingen.
Cell cultures
The F-MEL cells used in this study, 745A and TFP10, were grown in RPMI 1640 medium supplemented with 10% heat inactivated foetal calf serum (Eurobio). TFP10 is a Friend tumour cell line derived from FVP-induced erythrolaeukemia. 30 Cell cultures, for all experiments, were initiated in logarithmic growth phase at a cell density of 10 5 cells/ ml. DMSO was added at a final concentration of 2% (v/v), HMBA at 5 mM. The degree of differentiation was scored by counting the percentage of benzidine-positive cells as previously described. 31 Cells were routinely examined for mycoplasma contamination.
Western blot analysis
The cells were washed twice in PBS, resuspended gently in lysis buffer containing 25 mM Tris HCl pH 7.5, 10 mM EDTA, 50 mM NaF, 150 mM NaCl, 1 mM sodium orthovanadate, 1% NP-40, plus protease inhibitors, 32 and then incubated for 1 h at 48C. The lysate was centrifuged for 15 min at 10 0006g and total protein concentration in the supernatant was determined by the Micro BCA Protein Assay Reagent (Pierce). For each extract 30 mg of total cellular protein were resolved by 12% SDS-polyacrylamide gel electrophoresis (SDS ± PAGE). The separated proteins were transferred to PolyScreen membranes (NEN). Non specific binding to the membrane was reduced by pretreating overnight at 48C with 5% unfatted milk in TBS/ 0.05% Tween 20 (TBS-T). Membranes were then incubated 1 h at room temperature with first antibodies in TBS-T. Subsequently, membranes were incubated with anti-mouse (1 : 5000, Immunotech) or anti-rabbit (1 : 25000, Transduction Laboratories) antibody conjugated with horseradish peroxidase (HRP) for 1 h at room temperature. All the steps were followed by two washes for 15 min in TBS-T. The protein bands were detected as described in the ECL protocol (NEN) using Reflection autoradiography film.
Analysis of DNA fragmentation
The method was adapted from Gunji et al. 33 Briefly, 2610 7 cells were washed in PBS and resuspended in 50 ml of 50 mM Tris-HCl pH 8.0, 10 mM EDTA and 0.5 mg/ml proteinase K (Merck). After incubation at 508C for 1 h, 1 ml of 10 mg/ml RNaseA (Boehringer) was added for an additional 1 h at 378C. The samples were mixed with 25 ml of 10 mM EDTA (pH 8.0) containing 1% (w/v) low melting point agarose, 0.25% bromophenol blue and 40% sucrose at 708C. The DNA was separated in 2% agarose gels and visualized by UV illumination after ethidium bromide staining.
Cell survival assays
Cells were treated by adequate stimulus and after the appropriate time, viable cells were counted using the trypan blue dye exclusion assay. The number of total and viable cells was counted every 24 h. The per cent cell viability was determined by dividing the number of viable cells by the number of total cells. Apoptosis was also analyzed by staining using a mixture of ethidium bromide (EB) and acridine orange (AO). Twenty-five ml of cell suspension were mixed with 25 ml of a solution containing 500 mg/ml of EB and 150 mg/ml of AO. Cell morphology was studied using a fluorescence microscope. Live cells fluorescent green and dead cells orange. In advanced apoptosis, nuclei take the form of bright spherical beads which is distinguishable from that in necrotic cells (spheric form).
Cell cycle analysis
Cell cycle distribution was assessed by flow cytometry. After pelletization cells were resuspended in a hypotonic propidium iodide (PI) solution containing 25 mg/ml PI, 0.1% trisodium citrate dihydrate, and 0.1% v/v Triton X-100 in distilled water, and a 10% v/v RNAse solution (1 mg/ml in PBS with 0.5 mM EDTA). Cells were kept on ice for 20 ± 24 h and subsequently analyzed for DNA staining. Nuclear fluorescence was measured by quantitative flow cytometry and profiles were generated on a FacsCalibur analyser (Becton Dickinson).
